IL2 and hepatocellular carcinoma: Peritumoral delivery of IL-2 liposomes in rats with solid tumors induced by ascites-forming hepatoma (AH-66) cells led to substantial suppression of tumor growth, with immunohistochemical analysis revealing the accumulation of activated macrophages around the tumor site, contributing to enhanced antitumor responses [158].